Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 14,103,120 $ 13,723,681
Investments 106,000,091 7,182,325
Restricted cash 284,950 192,475
Prepaid expenses and other current assets 1,308,336 2,447,549
Total current assets 121,696,497 23,546,030
Restricted cash 384,950 477,425
Property and equipment, net 821,526 973,214
Operating lease right of use assets 2,841,189 3,062,920
Other assets 0 212,804
Total assets 125,744,162 28,272,393
Current liabilities:    
Notes payable 189,818 300,664
Accounts payable 2,081,812 3,178,516
Accrued expenses 9,398,225 11,030,506
Derivative liability 10,882 39,450
Operating lease liabilities, current 1,477,669 1,436,723
Current portion of long-term debt 12,764,915 15,908,214
Total current liabilities 25,923,321 31,894,073
Other long-term liabilities 0 44,411
Operating lease liabilities, noncurrent 2,855,140 3,238,631
Total liabilities 28,778,461 35,177,115
Stockholders' equity    
Preferred stock, $0.0001 par value; 10,000,000 shares authorized, no shares issued and outstanding at March 31, 2024 and December 31, 2023. 0 0
Common stock, $0.0001 par value; 300,000,000 shares authorized,10,507,237 and 4,423,683 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively 1,050 442
Additional paid-in capital 540,875,910 429,780,375
Accumulated deficit (443,582,754) (436,683,983)
Accumulated other comprehensive loss (328,505) (1,556)
Total stockholders’ equity 96,965,701 (6,904,722)
Total liabilities and stockholders’ equity $ 125,744,162 $ 28,272,393